Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics

Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics

Background Psoriasis is a chronic skin disease, and topical sequential therapy with a combination of calcipotriol and calcipotriol betamethasone is currently approved topical treatment. However, the exact mechanism by which this treatment regimen relieves psoriasis is unknown. Method We assembled a...

Full description

Bibliographic Details
Main Authors:	Jingwen Cui, Xiaomei Zhang, Jingwen Deng, Yuhong Yan, Danni Yao, Hao Deng, Jingjie Yu, Shuyan Ye, Ling Han, Xiaobo Yu, Chuanjian Lu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Journal of Dermatological Treatment
Subjects:	calcipotriol calcipotriol betamethasone psoriasis serum proteomics biomarker antibody microarray;dia-ms
Online Access:	http://dx.doi.org/10.1080/09546634.2023.2248318

Similar Items

Patients with male gender or greater body weight use smaller amounts of topical therapy in psoriasis
by: Minna E. Kubin, et al.
Published: (2018-02-01)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
by: Pinter A, et al.
Published: (2018-10-01)

Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis
by: Kim A. Papp, et al.
Published: (2022-10-01)

An open label prospective randomized trial to compare the efficacy of coal tar-salicylic acid ointment versus calcipotriol/betamethasone dipropionate ointment in the treatment of limited chronic plaque psoriasis
by: Sujay Khandpur, et al.
Published: (2014-01-01)

Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reports
by: Zoe Apalla, et al.
Published: (2022-07-01)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
by: Anderko M, et al.
Published: (2019-09-01)

Efficacy of Adding Topical Simvastatin to Topical Calcipotriol On Improvement of Cutaneous Plaque Psoriasis
by: Fariba Iraji, et al.
Published: (2015-03-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: sana imran, et al.
Published: (2014-08-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: sana imran, et al.
Published: (2014-08-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: Sana Imran, et al.
Published: (2014-08-01)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE)
by: Sascha Gerdes, et al.
Published: (2021-11-01)

Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review
by: Mathias Tiedemann Svendsen, et al.
Published: (2017-01-01)

Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris
by: Akimichi Morita, et al.
Published: (2018-07-01)

Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris
by: C. Queille-Roussel, et al.
Published: (2019-08-01)

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review
by: Tiago Torres, et al.
Published: (2023-09-01)

ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS
by: E. V. Sokolovskiy, et al.
Published: (2017-10-01)

Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment
by: Lidia Rudnicka, et al.
Published: (2021-11-01)

Topical Nicotinamide in Combination with Calcipotriol for the Treatment of Mild to Moderate Psoriasis: A Double-Blinded, Randomized, Comparative Study
by: Amir Hossein Siadat, et al.
Published: (2015-02-01)

Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp
by: Nuria García, et al.
Published: (2023-03-01)

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
by: Svendsen MT, et al.
Published: (2016-08-01)

Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
by: Deepthi Vasanthada, et al.
Published: (2014-04-01)

Improvements in Plaque Psoriasis Associated with Calcipotriol/Betamethasone Aerosol Foam Treatment: A Post Hoc Analysis of Non-interventional Studies and Clinical Experience
by: Sascha Gerdes, et al.
Published: (2024-02-01)

Effectiveness and tolerability of calcipotriol/betamethasone aerosol foam in patients with psoriasis vulgaris in real‐life setting: A prospective, noninterventional, multicenter observational study in Austria
by: Paulus Zenahlik, et al.
Published: (2023-06-01)

Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis
by: Ahmad Jalili, et al.
Published: (2024-02-01)

Treatment of Mild to Moderate Plaque Psoriasis with Pimecrolimus, Clobetasol, or Calcipotriol Cream: A comparative study
by: Bahir A.R. Mshimesh
Published: (2016-04-01)

Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis
by: Kim Papp, et al.
Published: (2022-05-01)

Disposable Stochastic Platform for the Simultaneous Determination of Calcipotriol and Betamethasone in Pharmaceutical and Surface Water Samples
by: Bianca-Maria Tuchiu, et al.
Published: (2023-08-01)

Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries
by: Deepak M. W. Balak, et al.
Published: (2021-10-01)

Topical therapies
by: Savaş Yaylı
Published: (2022-04-01)

Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients
by: A. L. Bakulev, et al.
Published: (2019-10-01)

Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use
by: Francisco J. Navarro-Triviño, et al.
Published: (2021-05-01)

Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo
by: Diala Alshiyab, et al.
Published: (2023-12-01)

Evaluation of Calcipotriol Solid Lipid Nanoparticles in Male BALB/c Mice Psoriasis Model
by: Mahsa Narenji, et al.
Published: (2023-11-01)

Frequency of genotypes and allelic polymorphisms of Vitamin D receptor in egyptian psoriatic patients and their association with disease severity, immune modulation of IL-22 levels and the response to topical calcipotriol treatment: A case control study
by: Haneya A A. Anani, et al.
Published: (2022-01-01)

Childhood vitiligo: Treatment paradigms
by: Amrinder Jit Kanwar, et al.
Published: (2012-01-01)

ROS-sensitive calcipotriol nano-micelles prepared by methoxypolyethylene glycol (mPEG) – modified polymer for the treatment of psoriasis
by: Yulin Hua, et al.
Published: (2022-12-01)

Localized scleroderma – current treatment options
by: Katarzyna Wolska-Gawron, et al.
Published: (2017-12-01)

Systematized inflammatory linear verrucous epidermal nevus moderately responsive to systemic acitretin and topical calcipotriol
by: Sanjay Singh, et al.
Published: (2018-01-01)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
by: Elisa Molinelli, et al.
Published: (2020-04-01)

Nano‐calcipotriol as a potent anti‐hepatic fibrosis agent
by: Yina Zhang, et al.
Published: (2023-10-01)